Heart benefits of Wegovy extend beyond weight loss

An analysis found that a shrinking waist size was responsible for only around a third of the cardiovascular benefits in people who took Wegovy

A new analysis of a major clinical trial affirmed that Wegovy, the popular obesity drug, lowers the risk of major heart issues like heart attacks and strokes in some adults, but showed that weight loss could not fully explain the cardiovascular benefits.
How else, exactly, the drug protects the heart remains a mystery.